{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:17:20Z","timestamp":1790648240939,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Endosane"},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF2013-02355704"],"award-info":[{"award-number":["RF2013-02355704"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Targeting fatty acid amide hydrolase (FAAH) is a promising therapeutic strategy to combat certain forms of pain, including migraine headache. FAAH inhibitors, such as the <jats:italic>O<\/jats:italic>-biphenyl-3-yl carbamate URB597, have been shown to produce anti-hyperalgesic effects in animal models of migraine. The objective of this study was to investigate the behavioral and biochemical effects of compounds ARN14633 and ARN14280, two URB597 analogs with improved solubility and bioavailability, in a migraine-specific rat model in which trigeminal hyperalgesia is induced by nitroglycerin (NTG) administration. ARN14633 (1\u2009mg\/kg, i.p.) and ARN14280 (3\u2009mg\/kg, i.p.) were administered to adult male Sprague-Dawley rats 3\u2009hours after NTG injection. One hour after the administration of either compound, rats were subjected to the orofacial formalin test. ARN14633 and ARN14280 attenuated NTG-induced nocifensive behavior and reduced transcription of genes encoding neuronal nitric oxide synthase, pain mediators peptides (calcitonin gene-related peptide, substance P) and pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1beta and 6) in the trigeminal ganglion, cervical spinal cord and medulla. Finally, both compounds strongly elevated levels of endocannabinoids and\/or other FAAH substrates in cervical spinal cord and medulla, and, to a lesser extent, in the trigeminal ganglia. The results indicate that the novel global FAAH inhibitors ARN14633 and ARN14280 elicit significant anti-hyperalgesic effects in a migraine-specific animal model and inhibit the associated peptidergic-inflammatory response. Although the precise mechanism underlying these effects remains to be elucidated, our results support further investigational studies of FAAH blockade as a potential therapeutic strategy to treat migraine conditions.<\/jats:p>","DOI":"10.1186\/s10194-022-01449-1","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T12:03:12Z","timestamp":1657195392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine"],"prefix":"10.1186","volume":"23","author":[{"given":"Rosaria","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Demartini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Zanaboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Francavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Reggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Realini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Scarpelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"1449_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fnins.2018.00172","volume":"12","author":"R Greco","year":"2018","unstructured":"Greco R, Demartini C, Zanaboni AM, Piomelli D, Tassorelli C (2018) Endocannabinoid system and migraine pain: an update. Front Neurosci 12:172. https:\/\/doi.org\/10.3389\/fnins.2018.00172","journal-title":"Front Neurosci"},{"key":"1449_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104624","volume":"134","author":"R Greco","year":"2020","unstructured":"Greco R, Demartini C, Zanaboni AM, Tumelero E, Reggiani A, Misto A, Piomelli D, Tassorelli C (2020) FAAH inhibition as a preventive treatment for migraine: a pre-clinical study. Neurobiol Dis 134:104624. https:\/\/doi.org\/10.1016\/j.nbd.2019.104624","journal-title":"Neurobiol Dis"},{"issue":"11","key":"1449_CR3","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1074\/jbc.270.11.6030","volume":"270","author":"F Desarnaud","year":"1995","unstructured":"Desarnaud F, Cadas H, Piomelli D (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 270(11):6030\u20136035. https:\/\/doi.org\/10.1074\/jbc.270.11.6030","journal-title":"J Biol Chem"},{"issue":"6604","key":"1449_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384(6604):83\u201387. https:\/\/doi.org\/10.1038\/384083a0","journal-title":"Nature"},{"issue":"1","key":"1449_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/neu.20080","volume":"61","author":"BF Cravatt","year":"2004","unstructured":"Cravatt BF, Lichtman AH (2004) The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol 61(1):149\u2013160. https:\/\/doi.org\/10.1002\/neu.20080","journal-title":"J Neurobiol"},{"issue":"1","key":"1449_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/mol.104.006353","volume":"67","author":"J Lo Verme","year":"2005","unstructured":"Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D (2005) The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67(1):15\u201319. https:\/\/doi.org\/10.1124\/mol.104.006353","journal-title":"Mol Pharmacol"},{"issue":"3","key":"1449_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1124\/jpet.106.111385","volume":"319","author":"J LoVerme","year":"2006","unstructured":"LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, Piomelli D (2006) Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319(3):1051\u20131061. https:\/\/doi.org\/10.1124\/jpet.106.111385","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1449_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/10409238.2015.1092944","volume":"51","author":"S Pontis","year":"2016","unstructured":"Pontis S, Ribeiro A, Sasso O, Piomelli D (2016) Macrophage-derived lipid agonists of PPAR-\u03b1 as intrinsic controllers of inflammation. Crit Rev Biochem Mol Biol 51(1):7\u201314. https:\/\/doi.org\/10.3109\/10409238.2015.1092944","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"1449_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","volume":"9","author":"S Kathuria","year":"2003","unstructured":"Kathuria S, Gaetani S, Fegley D, Vali\u00f1o F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9(1):76\u201381. https:\/\/doi.org\/10.1038\/nm803","journal-title":"Nat Med"},{"issue":"12","key":"1449_CR10","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1021\/jm021119g","volume":"46","author":"G Tarzia","year":"2003","unstructured":"Tarzia G, Duranti A, Tontini A, Piersanti G, Mor M, Rivara S, Plazzi PV, Park C, Kathuria S, Piomelli D (2003) Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. J Med Chem 46(12):2352\u20132360. https:\/\/doi.org\/10.1021\/jm021119g","journal-title":"J Med Chem"},{"issue":"51","key":"1449_CR11","doi-asserted-by":"publisher","first-page":"18620","DOI":"10.1073\/pnas.0509591102","volume":"102","author":"G Gobbi","year":"2005","unstructured":"Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102(51):18620\u201318625. https:\/\/doi.org\/10.1073\/pnas.0509591102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1449_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","volume":"62","author":"M Bortolato","year":"2007","unstructured":"Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62(10):1103\u20131110. https:\/\/doi.org\/10.1016\/j.biopsych.2006.12.001","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1449_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2013.01.003","volume":"138","author":"LV Panlilio","year":"2013","unstructured":"Panlilio LV, Justinova Z, Goldberg SR (2013) Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol Ther 138(1):84\u2013102. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.01.003","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1449_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1124\/jpet.108.142224","volume":"327","author":"M Scherma","year":"2008","unstructured":"Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinov\u00e1 Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR (2008) Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3\u2032-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. J Pharmacol Exp Ther 327(2):482\u2013490. https:\/\/doi.org\/10.1124\/jpet.108.142224","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1449_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","volume":"12","author":"D Piomelli","year":"2006","unstructured":"Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D (2006) Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12(1):21\u201338. https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00021.x","journal-title":"CNS Drug Rev"},{"issue":"3","key":"1449_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.bjp.0706510","volume":"147","author":"A Jayamanne","year":"2006","unstructured":"Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW (2006) Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol 147(3):281\u2013288. https:\/\/doi.org\/10.1038\/sj.bjp.0706510","journal-title":"Br J Pharmacol"},{"issue":"9","key":"1449_CR17","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1038\/npp.2015.62","volume":"40","author":"Z Justinova","year":"2015","unstructured":"Justinova Z, Panlilio LV, Moreno-Sanz G, Redhi GH, Auber A, Secci ME, Mascia P, Bandiera T, Armirotti A, Bertorelli R, Chefer SI, Barnes C, Yasar S, Piomelli D, Goldberg SR (2015) Effects of fatty acid amide hydrolase (FAAH) inhibitors in non-human primate models of nicotine reward and relapse. Neuropsychopharmacology 40(9):2185\u20132197. https:\/\/doi.org\/10.1038\/npp.2015.62","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"1449_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.biopsych.2010.07.009","volume":"69","author":"P Mascia","year":"2011","unstructured":"Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Rdhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, Goldberg SR (2011) Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biol Psychiatry 69(7):633\u2013641. https:\/\/doi.org\/10.1016\/j.biopsych.2010.07.009","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1449_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.107.119941","volume":"322","author":"R Russo","year":"2007","unstructured":"Russo R, LoVerme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D (2007) The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3\u2032-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J Pharmacol Exp Ther 322(1):236\u2013242. https:\/\/doi.org\/10.1124\/jpet.107.119941","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1449_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1476-5381.2012.02028.x","volume":"167","author":"BN Okine","year":"2012","unstructured":"Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SP, Barrett DA, Kendall DA, Bennett AJ, Chapman V (2012) Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. Br J Pharmacol 167(3):627\u2013640. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02028.x","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1449_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096396","volume":"9","author":"AT Hama","year":"2014","unstructured":"Hama AT, Germano P, Varghese MS, Cravatt BF, Milne GT, Pearson JP, Sagen J (2014) Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain. PLoS One 9(5):e96396. https:\/\/doi.org\/10.1371\/journal.pone.0096396","journal-title":"PLoS One"},{"issue":"2","key":"1449_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109\u2013110. https:\/\/doi.org\/10.1016\/0304-3959(83)90201-4","journal-title":"Pain"},{"issue":"12","key":"1449_CR23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1177\/0333102414566862","volume":"35","author":"R Greco","year":"2015","unstructured":"Greco R, Bandiera T, Mangione AS, Demartini C, Siani F, Nappi G, Sandrini G, Guijarro A, Armirotti A, Piomelli D, Tassorelli C (2015) Effects of peripheral FAAH blockade on NTG-induced hyperalgesia--evaluation of URB937 in an animal model of migraine. Cephalalgia 35(12):1065\u20131076. https:\/\/doi.org\/10.1177\/0333102414566862","journal-title":"Cephalalgia"},{"key":"1449_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105157","volume":"147","author":"R Greco","year":"2021","unstructured":"Greco R, Demartini C, Zanaboni AM, Casini I, De Icco R, Reggiani A, Misto A, Piomelli D, Tassorelli C (2021) Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine. Neurobiol Dis 147:105157. https:\/\/doi.org\/10.1016\/j.nbd.2020.105157","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1449_CR25","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00213-015-4140-6","volume":"233","author":"LV Panlilio","year":"2016","unstructured":"Panlilio LV, Thorndike EB, Nikas SP, Alapafuja SO, Bandiera T, Cravatt BF, Makriyannis A, Piomelli D, Goldberg SR, Justinova Z (2016) Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats. Psychopharmacology 233(10):1879\u20131888. https:\/\/doi.org\/10.1007\/s00213-015-4140-6","journal-title":"Psychopharmacology"},{"issue":"8","key":"1449_CR26","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.euroneuro.2015.04.001","volume":"25","author":"C Nozaki","year":"2015","unstructured":"Nozaki C, Markert A, Zimmer A (2015) Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice. Eur Neuropsychopharmacol 25(8):1388\u20131396. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.04.001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"13","key":"1449_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1177\/0333102416678000","volume":"37","author":"R Greco","year":"2017","unstructured":"Greco R, Demartini C, Zanaboni AM, Redavide E, Pampalone S, Toldi J, F\u00fcl\u00f6p F, Blandini F, Nappi G, Sandrini G, V\u00e9csei L, Tassorelli C (2017) Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: targets and anti-migraine mechanisms. Cephalalgia 37(13):1272\u20131284. https:\/\/doi.org\/10.1177\/0333102416678000","journal-title":"Cephalalgia"},{"issue":"1","key":"1449_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10194-017-0804-4","volume":"18","author":"C Demartini","year":"2017","unstructured":"Demartini C, Tassorelli C, Zanaboni AM, Tonsi G, Francesconi O, Nativi C, Greco R (2017) The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model. J Headache Pain 18(1):94. https:\/\/doi.org\/10.1186\/s10194-017-0804-4","journal-title":"J Headache Pain"},{"issue":"10","key":"1449_CR29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nn.2632","volume":"13","author":"JR Clapper","year":"2010","unstructured":"Clapper JR, Moreno-Sanz G, Russo R, Guijarro A, Vacondio F, Duranti A (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat Neurosci 13(10):1265\u20131270. https:\/\/doi.org\/10.1038\/nn.2632","journal-title":"Nat Neurosci"},{"issue":"26","key":"1449_CR30","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.jchromb.2009.01.008","volume":"877","author":"G Astarita","year":"2009","unstructured":"Astarita G, Piomelli D (2009) Lipidomic analysis of endocannabinoid metabolism in biological samples. J Chromatogr B Anal Technol Biomed Life Sci 877(26):2755\u20132767. https:\/\/doi.org\/10.1016\/j.jchromb.2009.01.008","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"9","key":"1449_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.115","volume":"17","author":"V Di Marzo","year":"2018","unstructured":"Di Marzo V (2018) New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov 17(9):623\u2013639. https:\/\/doi.org\/10.1038\/nrd.2018.115","journal-title":"Nat Rev Drug Discov"},{"key":"1449_CR32","volume-title":"Endocannabinoidome","author":"FA Iannotti","year":"2018","unstructured":"Iannotti FA, Piscitelli F (2018) In: eLS (ed) Endocannabinoidome. John Wiley & Sons, ltd, Chichester"},{"issue":"7","key":"1449_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1517\/17460440903018857","volume":"4","author":"K Ahn","year":"2009","unstructured":"Ahn K, Johnson DS, Cravatt BF (2009) Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opin Drug Discovery 4(7):763\u2013784. https:\/\/doi.org\/10.1517\/17460440903018857","journal-title":"Expert Opin Drug Discovery"},{"issue":"1","key":"1449_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/S0029665113003649","volume":"73","author":"RG Pertwee","year":"2014","unstructured":"Pertwee RG (2014) Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. Proc Nutr Soc 73(1):96\u2013105. https:\/\/doi.org\/10.1017\/S0029665113003649","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"1449_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/head.14267","volume":"62","author":"R Greco","year":"2022","unstructured":"Greco R, Demartini C, Zanaboni AM, Francavilla M, De Icco R, Ahmad L, Tassorelli C (2022) The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain. Headache 62(3):227\u2013240. https:\/\/doi.org\/10.1111\/head.14267","journal-title":"Headache"},{"issue":"1","key":"1449_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 16(1):9\u201329. https:\/\/doi.org\/10.1038\/s41582-019-0284-z","journal-title":"Nat Rev Neurol"},{"issue":"1\u20132","key":"1449_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejphar.2007.01.076","volume":"562","author":"E Murillo-Rodr\u00edguez","year":"2007","unstructured":"Murillo-Rodr\u00edguez E, V\u00e1zquez E, Mill\u00e1n-Aldaco D, Palomero-Rivero M, Drucker-Colin R (2007) Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. Eur J Pharmacol 562(1\u20132):82\u201391. https:\/\/doi.org\/10.1016\/j.ejphar.2007.01.076","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1449_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/sj.bjp.0707313","volume":"151","author":"E Soria-G\u00f3mez","year":"2007","unstructured":"Soria-G\u00f3mez E, Matias I, Rueda-Orozco PE, Cisneros M, Petrosino S, Navarro L, Di Marzo V, Prosp\u00e9ro-Garc\u00eda O (2007) Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Br J Pharmacol 151(7):1109\u20131116. https:\/\/doi.org\/10.1038\/sj.bjp.0707313","journal-title":"Br J Pharmacol"},{"issue":"10","key":"1449_CR39","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/cells10102543","volume":"10","author":"R Greco","year":"2021","unstructured":"Greco R, Demartini C, Francavilla M, Zanaboni AM, Tassorelli C (2021) Dual inhibition of FAAH and MAGL counteracts migraine-like pain and behavior in an animal model of migraine. Cells 10(10):2543. https:\/\/doi.org\/10.3390\/cells10102543","journal-title":"Cells"},{"issue":"5","key":"1449_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41386-020-00936-w","volume":"46","author":"MP Paulus","year":"2021","unstructured":"Paulus MP, Stein MB, Simmons AN, Risbrough VB, Halter R, Chaplan SR (2021) The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial. Neuropsychopharmacology 46(5):1011\u20131019. https:\/\/doi.org\/10.1038\/s41386-020-00936-w","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1449_CR41","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.apsb.2019.10.006","volume":"10","author":"H Deng","year":"2020","unstructured":"Deng H, Li W (2020) Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders. Acta Pharm Sin B 10(4):582\u2013602. https:\/\/doi.org\/10.1016\/j.apsb.2019.10.006","journal-title":"Acta Pharm Sin B"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01449-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T12:03:19Z","timestamp":1657195399000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01449-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01449-1","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"29 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}